TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
-0.55%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.51B
AUM Growth
+$111M
(+8%)
Cap. Flow
+$219M
Cap. Flow
% of AUM
14.5%
Top 10 Holdings %
Top 10 Hldgs %
37.54%
Holding
194
New
40
Increased
63
Reduced
17
Closed
11
Top Buys
| 1 |
Galapagos
GLPG
|
$40.2M |
| 2 |
Relay Therapeutics
RLAY
|
$18.5M |
| 3 |
Replimune Group
REPL
|
$18.2M |
| 4 |
Legend Biotech
LEGN
|
$14.6M |
| 5 |
Immunocore
IMCR
|
$13.3M |
Top Sells
| 1 |
ITOS
iTeos Therapeutics
ITOS
|
$16.8M |
| 2 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$13M |
| 3 |
Immunome
IMNM
|
$10.5M |
| 4 |
ANI Pharmaceuticals
ANIP
|
$7.32M |
| 5 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$6.4M |
Sector Composition
| 1 | Healthcare | 94.65% |
| 2 | Technology | 1.65% |
| 3 | Communication Services | 1.35% |
| 4 | Consumer Discretionary | 0.56% |
| 5 | Financials | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Soleno Therapeutics
SLNO
$3.56B
| $2.25M | 0.15% |
+50,000
| New | +$2.25M |
|
102
CareDx
CDNA
$678M
| $2.14M | 0.14% |
+100,000
| New | +$2.14M |
|
103
Genmab
GMAB
$16.7B
| $2.09M | 0.14% |
100,000
| – | – |
|
104
Applied Therapeutics
APLT
$73.7M
| $2.08M | 0.14% |
2,428,169
-301,831
| -11% | -$258K |
|
105
Idexx Laboratories
IDXX
$50.7B
| $2.07M | 0.14% |
+5,000
| New | +$2.07M |
|
106
Bolt Biotherapeutics
BOLT
$9.29M
| $2.04M | 0.14% |
190,639
| – | – |
|
107
Fortrea Holdings
FTRE
$971M
| $1.87M | 0.12% |
+100,000
| New | +$1.87M |
|
|
ITOS
108
DELISTED
iTeos Therapeutics
ITOS
| $1.7M | 0.11% |
221,716
-2,186,084
| -91% | -$16.8M |
|
109
JPMorgan Chase
JPM
$824B
| $1.58M | 0.1% |
6,601
+1,928
| +41% | +$462K |
|
110
Walmart
WMT
$793B
| $1.57M | 0.1% |
17,423
+4,698
| +37% | +$424K |
|
|
THRD
111
DELISTED
Third Harmonic Bio
THRD
| $1.54M | 0.1% |
+150,000
| New | +$1.54M |
|
112
Erasca
ERAS
$406M
| $1.51M | 0.1% |
602,915
+100,000
| +20% | +$251K |
|
113
Visa
V
$681B
| $1.49M | 0.1% |
4,718
+1,400
| +42% | +$442K |
|
114
Walt Disney
DIS
$211B
| $1.46M | 0.1% |
13,095
+4,261
| +48% | +$474K |
|
115
Microsoft
MSFT
$3.76T
| $1.44M | 0.1% |
3,413
+1,163
| +52% | +$490K |
|
116
Regeneron Pharmaceuticals
REGN
$59.8B
| $1.42M | 0.09% |
+2,000
| New | +$1.42M |
|
117
Viatris
VTRS
$12.3B
| $1.42M | 0.09% |
114,316
+40,435
| +55% | +$503K |
|
118
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.4M | 0.09% |
3,099
+1,020
| +49% | +$462K |
|
119
Verastem
VSTM
$585M
| $1.4M | 0.09% |
270,000
| – | – |
|
120
MindMed
MNMD
$689M
| $1.39M | 0.09% |
+200,000
| New | +$1.39M |
|
121
PayPal
PYPL
$66.5B
| $1.34M | 0.09% |
15,714
+4,615
| +42% | +$394K |
|
122
Procter & Gamble
PG
$370B
| $1.33M | 0.09% |
7,962
+2,817
| +55% | +$472K |
|
123
Syndax Pharmaceuticals
SNDX
$1.39B
| $1.32M | 0.09% |
+100,000
| New | +$1.32M |
|
124
Home Depot
HD
$406B
| $1.3M | 0.09% |
3,353
+999
| +42% | +$389K |
|
125
Beam Therapeutics
BEAM
$1.9B
| $1.24M | 0.08% |
50,000
-120,000
| -71% | -$2.98M |
|